Insider trade

Officer sold ~$13K of JAZZ shares in the open market

Traded Nov 18, 2025 · Filed Nov 21, 2025

Why it stands out

Jazz Pharmaceuticals's SVP, Chief Accounting Officer sold $13K of Jazz Pharmaceuticals shares. It happened by itself, for taxes or pay.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Officer<$25KPre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$12,535

Shares × reported transaction price

Timing vs results

13 days after results of Nov 5, 2025, 55 days before results of Jan 12, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references an employee stock purchase plan

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	−0.2%	+3.7%	−3.9%
30 days	−4.1%	+3.9%	−8.0%
90 days	−4.2%	+3.9%	−8.0%
180 days	+35.1%	+12.5%	+22.6%

Past results only. Not a forecast.

The Reporting Person acquired 69 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 30, 2025.

Officer sold

10mo ago

Jazz Pharmaceuticals's SVP, Technical Operations sold $379K of Jazz Pharmaceuticals shares. Nobody planned it ahead of time.

10mo ago

Routine share withholding; mechanical by default.

Automatic sale10mo ago